Correlation Between Molecular Partners and Dyadic International
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Dyadic International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Dyadic International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Dyadic International, you can compare the effects of market volatilities on Molecular Partners and Dyadic International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Dyadic International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Dyadic International.
Diversification Opportunities for Molecular Partners and Dyadic International
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Molecular and Dyadic is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Dyadic International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyadic International and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Dyadic International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyadic International has no effect on the direction of Molecular Partners i.e., Molecular Partners and Dyadic International go up and down completely randomly.
Pair Corralation between Molecular Partners and Dyadic International
Given the investment horizon of 90 days Molecular Partners AG is expected to under-perform the Dyadic International. But the stock apears to be less risky and, when comparing its historical volatility, Molecular Partners AG is 1.08 times less risky than Dyadic International. The stock trades about -0.08 of its potential returns per unit of risk. The Dyadic International is currently generating about 0.43 of returns per unit of risk over similar time horizon. If you would invest 109.00 in Dyadic International on August 28, 2024 and sell it today you would earn a total of 82.00 from holding Dyadic International or generate 75.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Dyadic International
Performance |
| Timeline |
| Molecular Partners |
| Dyadic International |
Molecular Partners and Dyadic International Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Dyadic International
The main advantage of trading using opposite Molecular Partners and Dyadic International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Dyadic International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyadic International will offset losses from the drop in Dyadic International's long position.| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
| Dyadic International vs. Werewolf Therapeutics | Dyadic International vs. Edgewise Therapeutics | Dyadic International vs. Celcuity LLC | Dyadic International vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |